Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Reticulocytosis
ADR ID BADD_A03833
ADR Hierarchy
01      Blood and lymphatic system disorders
01.07      Red blood cell disorders
01.07.02      Red blood cell abnormal findings NEC
01.07.02.002      Reticulocytosis
Description An increase in circulating RETICULOCYTES, which is among the simplest and most reliable signs of accelerated ERYTHROCYTE production. Reticulocytosis occurs during active BLOOD regeneration (stimulation of red bone marrow) and in certain types of ANEMIA, particularly CONGENITAL HEMOLYTIC ANEMIA. [MeSH]
MedDRA Code 10038796
MeSH ID D045262
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Reticulocytosis | Reticulocytoses
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00028Acetohydroxamic acid--
BADD_D00076Allopurinol--
BADD_D00356Carbamazepine--
BADD_D00602Delamanid--
BADD_D01010Gemcitabine hydrochloride--
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01933Ribavirin--
BADD_D02215Ticlopidine--
BADD_D02216Ticlopidine hydrochloride--
BADD_D02345Venetoclax0.000168%
BADD_D02471Oxygen0.001239%
The 1th Page    1    Total 1 Pages